PubMed Health⌕ Search

PubMed · 9891705

Ankylosing spondylitis. Clinical features.

Abstract

The clinical spectrum of ankylosing spondylitis (AS) is wider than just symptomatic sacroiliitis. The disease may be atypical or may occur as forme fruste. Atypical cases are encompassed in classification criteria for the whole family of spondyloarthropathies. AS may result primarily from additive genetic variability. Nonsteroidal anti-inflammatory drugs and physical exercise remain the cornerstone in the treatment of AS. Core sets for the assessment of the disease now exist for different treatment settings.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S van der Linden, D van der Heijde. 1998. Ankylosing spondylitis. Clinical features.. https://doi.org/10.1016/s0889-857x(05)70036-3

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[HLA-B27 polymorphism and spondyloarthropathies].

The association of HLA-B27 with ankylosing spondylitis (AS), and other spondyloarthropathies (SpA), remains as one of the strongest between HLA molecules and human disease. Since it was reported, in 1973, it has been extensively studied in order to understand the underlying pathogenic mechanism. The objective of this article is to review the current knowledge on the structure and polymorphism of HLA-B27 molecule, as well as describe the main pathogenic hypotheses trying to explain its association with AS.

HLA-B27 Antigen↗